Strong Market Presence Affidea operates a vast network of 366 centers across 15 European countries, providing opportunities to offer scalable solutions such as advanced medical technologies, AI-driven diagnostic tools, and digital health platforms to enhance patient care and operational efficiency.

Technological Innovation With recent strategic partnerships in AI for skin cancer and breast imaging, along with substantial investments in digital health solutions, there is a clear openness to adopting innovative technologies that can improve diagnostic accuracy and patient outcomes.

Growth & Expansion Recent acquisitions in Switzerland and investments in new clinics highlight a focus on expanding healthcare services, creating opportunities for medical device, imaging, and healthcare IT vendors to collaborate on integrated solutions that support their growth.

Financial Scale Generating revenue between $250M and $500M and employing over 10,000 staff, Affidea offers a significant customer base for B2B sales, especially in areas of medical imaging, diagnostic equipment, and enterprise healthcare management platforms.

Leadership & Support Backed by the stable ownership of Groupe Bruxelles Lambert and a focus on long-term value, Affidea is positioned as a reliable partner interested in quality service and technological partnerships that align with their strategic expansion and patient safety priorities.